Apolipoprotein E inhibits cerebrovascular pericyte mobility through a RhoA protein-mediated pathway

Journal of Biological Chemistry

Volumn 290, Issue 22, 2015, Pages 14208-14217

  Casey, Caroline S ^a   Atagi, Yuka ^a   Yamazaki, Yu ^a   Shinohara, Mitsuru ^a   Tachibana, Masaya ^a   Fu, Yuan ^a   Bu, Guojun ^a   Kanekiyo, Takahisa ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; LIPOPROTEINS; NEURODEGENERATIVE DISEASES; NEURONS;

ACTIN CYTOSKELETON; ALZHEIMER DISEASE; APOLIPOPROTEIN E; APOLIPOPROTEIN E (APOE); BIOCHEMICAL PROPERTIES; BLOOD-BRAIN BARRIER; CONTRACTILE CELLS; LOW DENSITY LIPOPROTEIN RECEPTORS;

PROTEINS;

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ACTIN; CHOLESTEROL; CULTURE MEDIUM; LRP1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ACTIN FILAMENT; ALZHEIMER DISEASE; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; BRAIN; BRAIN CIRCULATION; CELL CULTURE; CELL MOTION; CHEMISTRY; CULTURE MEDIUM; CYTOSKELETON; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; METABOLISM; VASCULARIZATION;

ACTINS; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; CHOLESTEROL; CULTURE MEDIA; CULTURE MEDIA, CONDITIONED; CYTOSKELETON; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; PERICYTES; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING;

EID: 84930655847     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.625251     Document Type: Article

References (51)

1. Mahley, R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630
2. Bu, G. (2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 10, 333-344
3. Hui, D. Y., Harmony, J. A., Innerarity, T. L., and Mahley, R. W. (1980) Immunoregulatory plasma lipoproteins: role of apoprotein E and apoprotein B. J. Biol. Chem. 255, 11775-11781
4. Kanekiyo, T., Xu, H., and Bu, G. (2014) ApoE and Aβ in Alzheimer's disease: accidental encounters or partners? Neuron 81, 740-754
5. Swertfeger, D. K., Bu, G., and Hui, D. Y. (2002) Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J. Biol. Chem. 277, 4141-4146
6. 1 phase. J. Biol. Chem. 273, 20156-20161
7. Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H., and Bu, G. (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106-118
8. Schächter, F., Faure-Delanef, L., Guénot, F., Rouger, H., Froguel, P., Lesueur-Ginot, L., and Cohen, D. (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 6, 29-32
9. Morikawa, M., Fryer, J. D., Sullivan, P. M., Christopher, E. A., Wahrle, S. E., DeMattos, R. B., O'Dell, M. A., Fagan, A. M., Lashuel, H. A., Walz, T., Asai, K., and Holtzman, D. M. (2005) Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta. Neurobiol. Dis. 19, 66-76
10. Xu, Q., Bernardo, A., Walker, D., Kanegawa, T., Mahley, R. W., and Huang, Y. (2006) Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26, 4985-4994
11. Wilhelmus, M. M., Otte-Höller, I., Davis, J., Van Nostrand, W. E., de Waal, R. M., and Verbeek, M. M. (2005) Apolipoprotein E genotype regulates amyloid-ô cytotoxicity. J. Neurosci. 25, 3621-3627
12. Bergers, G., and Song, S. (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro. Oncol. 7, 452-464
13. Winkler, E. A., Bell, R. D., and Zlokovic, B. V. (2011) Central nervous system pericytes in health and disease. Nat. Neurosci. 14, 1398-1405
14. Zlokovic, B. V. (2013) Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol. 70, 440-444
15. Göritz, C., Dias, D. O., Tomilin, N., Barbacid, M., Shupliakov, O., and Frisén, J. (2011) A pericyte origin of spinal cord scar tissue. Science 333, 238-242
16. Nishitsuji, K., Hosono, T., Nakamura, T., Bu, G., and Michikawa, M. (2011) Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J. Biol. Chem. 286, 17536-17542
17. Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., Berk, B. C., and Zlokovic, B. V. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516
18. Zhao, J., Fu, Y., Liu, C. C., Shinohara, M., Nielsen, H. M., Dong, Q., Kanekiyo, T., and Bu, G. (2014) Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/ retinoic acid receptor pathway. J. Biol. Chem. 289, 11282-11292
19. Krul, E. S., Tikkanen, M. J., and Schonfeld, G. (1988) Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function. J. Lipid Res. 29, 1309-1325
20. Li, Y., Lu, W., and Bu, G. (2003) Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration. FEBS Lett. 555, 346-350
21. Song, H., Li, Y., Lee, J., Schwartz, A. L., and Bu, G. (2009) Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res. 69, 879-886
22. Castoreno, A. B., Smurnyy, Y., Torres, A. D., Vokes, M. S., Jones, T. R., Carpenter, A. E., and Eggert, U. S. (2010) Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis. Nat. Chem. Biol. 6, 457-463
23. Warshawsky, I., Bu, G., and Schwartz, A. L. (1993) 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo. J. Clin. Invest. 92, 937-944
24. Shinohara, M., Petersen, R. C., Dickson, D. W., and Bu, G. (2013) Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation. Acta Neuropathol. 125, 535-547
25. -/-, and human apoE transgenic mice. J. Biol. Chem. 274, 30001-30007
26. Fagan, A. M., Younkin, L. H., Morris, J. C., Fryer, J. D., Cole, T. G., Younkin, S. G., and Holtzman, D. M. (2000) Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann. Neurol. 48, 201-210
27. Bu, G., and Marzolo, M. P. (2000) Role of rap in the biogenesis of lipoprotein receptors. Trends Cardiovasc. Med. 10, 148-155
28. Ridley, A. J. (2001) Rho GTPases and cell migration. J. Cell Sci. 114, 2713-2722
29. Etienne-Manneville, S., and Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-635
30. Kovac, A., Erickson, M. A., and Banks, W. A. (2011) Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J. Neuroinflamm. 8, 139
31. Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., and Sofroniew, M. V. (2004) Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24, 2143-2155
32. Silver, J., and Miller, J. H. (2004) Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-156
33. Seitz, A., Kragol, M., Aglow, E., Showe, L., and Heber-Katz, E. (2003) Apolipoprotein E expression after spinal cord injury in the mouse. J. Neurosci. Res. 71, 417-426
34. Jha, A., Lammertse, D. P., Coll, J. R., Charlifue, S., Coughlin, C. T., Whiteneck, G. G., and Worley, G. (2008) Apolipoprotein E epsilon4 allele and outcomes of traumatic spinal cord injury. J. Spinal Cord Med. 31, 171-176
35. Senger, D. R., and Davis, G. E. (2011) Angiogenesis. Cold Spring Harb. Perspect. Biol. 3, a005090
36. Stratman, A. N., Malotte, K. M., Mahan, R. D., Davis, M. J., and Davis, G. E. (2009) Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114, 5091-5101
37. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936
38. Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., and Tavazoie, S. F. (2012) Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151, 1068-1082
39. Zlokovic, B. V. (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723-738
40. Fernández-López, D., Faustino, J., Daneman, R., Zhou, L., Lee, S. Y., Derugin, N., Wendland, M. F., and Vexler, Z. S. (2012) Blood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat. J. Neurosci. 32, 9588-9600
41. Iadecola, C. (2013) The pathobiology of vascular dementia. Neuron 80, 844-866
42. Dore-Duffy, P., Owen, C., Balabanov, R., Murphy, S., Beaumont, T., and Rafols, J. A. (2000) Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc. Res. 60, 55-69
43. Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., Goate, A. M., Bales, K. R., Paul, S. M., Bateman, R. J., and Holtzman, D. M. (2011) Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci. Transl. Med. 3, 89ra57
44. Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B., Alexander, G. E., Klunk, W. E., Mathis, C. A., Price, J. C., Aizenstein, H. J., DeKosky, S. T., and Caselli, R. J. (2009) Fibrillar amyloid-ô burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 106, 6820-6825
45. Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., Hansen, J. C., Sullivan, P. M., and Paul, S. M. (2009) Human APOE isoform-dependent effects on brain β-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29, 6771-6779
46. de la Torre, J. C. (2002) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33, 1152-1162
47. Wennerberg, K., Rossman, K. L., and Der, C. J. (2005) The Ras superfamily at a glance. J. Cell Sci. 118, 843-846
48. Pankov, R., and Yamada, K. M. (2002) Fibronectin at a glance. J. Cell Sci. 115, 3861-3863
49. Kanekiyo, T., and Bu, G. (2014) The low-density lipoprotein receptorrelated protein 1 and amyloid-ô clearance in Alzheimer's disease. Front. Aging Neurosci. 6, 93
50. Herz, J., and Strickland, D. K. (2001) LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779-784
51. Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., and Strickland, D. K. (2008) LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol. Rev. 88, 887-918